Aldeyra Therapeutics (FRA:137) Other Operating Expense : €-0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aldeyra Therapeutics Other Operating Expense?

Aldeyra Therapeutics's Other Operating Expense for the three months ended in Jun. 2024 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.00 Mil.

Aldeyra Therapeutics's quarterly Other Operating Expense declined from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€-0.00 Mil) and declined from Mar. 2024 (€-0.00 Mil) to Jun. 2024 (€-0.00 Mil).

Aldeyra Therapeutics's annual Other Operating Expense declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) and declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil).

Aldeyra Therapeutics Other Operating Expense Historical Data

The historical data trend for Aldeyra Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aldeyra Therapeutics Other Operating Expense Chart

Aldeyra Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

Aldeyra Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Aldeyra Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Aldeyra Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Aldeyra Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aldeyra Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aldeyra Therapeutics Inc (FRA:137) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ALDX:USA 137:Germany

Address

131 Hartwell Avenue, Suite 320, Lexington, MA, USA, 02421

Website

https://www.aldeyra.com

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Aldeyra Therapeutics Headlines

No Headlines